卫光生物(002880) - 2025 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2025 was ¥272,803,789.48, a decrease of 17.63% compared to the same period last year[5] - Net profit attributable to shareholders was ¥50,214,191.78, down 31.06% year-over-year[5] - The basic earnings per share decreased to ¥0.2214, reflecting a decline of 31.06% compared to the previous year[5] - Total operating revenue for the current period was CNY 790,899,107.60, a decrease of 7.4% from CNY 854,101,695.51 in the previous period[17] - Net profit for the current period was CNY 157,817,918.30, a decline of 13.5% compared to CNY 182,526,379.42 in the previous period[18] - Earnings per share (EPS) for the current period was CNY 0.6960, down from CNY 0.8056 in the previous period[18] Assets and Liabilities - Total assets at the end of the reporting period were ¥3,394,096,344.18, an increase of 2.93% from the end of the previous year[5] - Total assets increased to CNY 3,394,096,344.18, compared to CNY 3,297,444,233.19 in the previous period, reflecting a growth of 2.9%[16] - Total liabilities decreased to CNY 1,037,403,561.90, down from CNY 1,053,207,768.02, a reduction of 1.5%[16] - Total equity attributable to shareholders increased to CNY 2,323,925,868.39, up from CNY 2,211,425,331.14, representing a growth of 5.1%[16] Cash Flow - The company's cash flow from operating activities for the year-to-date was ¥91,120,401.29, down 9.76% compared to the same period last year[5] - Operating cash inflow for the current period was CNY 842,667,774.40, an increase of 3.5% from CNY 814,550,758.10 in the previous period[19] - Net cash flow from operating activities decreased to CNY 91,120,401.29, down 10.8% from CNY 100,979,444.84 in the previous period[19] - Cash outflow from investing activities totaled CNY 389,923,297.69, compared to CNY 202,871,023.87 in the previous period, indicating a significant increase in investment spending[20] - Net cash flow from investing activities was -CNY 225,188,536.58, worsening from -CNY 202,739,405.97 in the previous period[20] - Cash inflow from financing activities decreased to CNY 131,067,909.27, down 46.0% from CNY 243,023,091.82 in the previous period[20] - Net cash flow from financing activities was -CNY 61,095,218.93, a decline from CNY 106,122,041.96 in the previous period[20] - The ending cash and cash equivalents balance was CNY 79,567,082.84, a decrease from CNY 255,807,762.34 in the previous period[20] Investments and Shareholder Information - The company received government subsidies amounting to ¥1,515,280.00 during the reporting period[7] - The number of ordinary shareholders at the end of the reporting period was 12,496[10] - The largest shareholder, Shenzhen Guangming District State-owned Assets Supervision and Administration Bureau, holds 65.25% of the shares[10] - The company reported a significant increase in investment income, rising to ¥3,152,675.52, a 2708.23% increase compared to the previous year[9] - The company reported an investment income of CNY 3,152,675.52, compared to a loss of CNY 120,874.33 in the previous period[17] - The company plans to participate in a land auction for the smart industry base project, with significant developments expected in 2025[12] - The company is set to issue A-shares to specific investors in October 2025, aiming to enhance capital structure[12] Asset Composition - The company's cash and cash equivalents decreased to ¥79,599,872.52 from ¥274,763,226.74, representing a decline of approximately 71%[14] - Accounts receivable increased to ¥175,464,371.34 from ¥132,861,636.40, showing a growth of about 32%[14] - Inventory rose significantly to ¥966,635,488.07 from ¥793,462,099.62, indicating an increase of approximately 22%[14] - Total current assets decreased to ¥1,345,357,063.60 from ¥1,527,590,386.50, reflecting a decline of around 12%[14] - Non-current assets, including investment properties, increased to ¥869,342,520.53 from ¥800,940,962.12, marking a growth of about 8.6%[14] - The company reported a notable increase in prepayments to ¥6,394,700.16 from ¥2,133,760.33, which is an increase of approximately 200%[14] - The company’s long-term intangible assets rose to ¥152,383,603.43 from ¥134,911,011.12, reflecting an increase of about 12.9%[14] - The company’s goodwill remained stable at ¥19,230,057.19, indicating no change during the reporting period[14] Research and Development - Research and development expenses for the current period were CNY 35,629,988.19, a decrease of 6.5% from CNY 38,106,155.61[17] - Deferred tax assets increased to CNY 10,465,681.38 from CNY 9,969,591.92, indicating a growth of 5.0%[15]